How I manage pregnancy in women with Glanzmann thrombasthenia.
Journal
Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509
Informations de publication
Date de publication:
28 04 2022
28 04 2022
Historique:
received:
25
10
2021
accepted:
02
03
2022
pubmed:
15
3
2022
medline:
3
5
2022
entrez:
14
3
2022
Statut:
ppublish
Résumé
Glanzmann thrombasthenia (GT) is a rare inherited platelet function disorder caused by a quantitative and/or qualitative defect of the αIIbβ3 integrin. Pregnancy and delivery are recognized risk periods for bleeding in women with GT. The newborn may also be affected by fetal and neonatal immune thrombocytopenia induced by the transplacental passage of maternal anti-αIIbβ3 antibodies, which can lead to severe hemorrhage and fetal loss. Pregnancy in women with GT thus requires a multidisciplinary approach, including prepregnancy counseling and a treatment plan for delivery for both the mother and child. In this article, we summarize the current knowledge on pregnancy in women with GT and describe how we manage this severe platelet disorder in our clinical practice.
Identifiants
pubmed: 35286390
pii: S0006-4971(22)00374-3
doi: 10.1182/blood.2021011595
doi:
Substances chimiques
Platelet Glycoprotein GPIIb-IIIa Complex
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2632-2641Informations de copyright
© 2022 by The American Society of Hematology.